Clinical trial
A Pilot Study of Romidepsin for Therapy of Graft-versus-Host Disease
NCT02203578 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Romidepsin for Therapy of Graft-versus-Host Disease
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 30, 2014
- Completion date
- June 14, 2016
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
graft versus host disease